MyFinsight
Home
Blog
About
Eikon Therapeutics, Inc. (EIKN)
Eikon Therapeutics, Inc. (EIKN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$65,209K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Accrued expenses and other curre...
Depreciation expense
Others
Negative Cash Flow Breakdown
Purchase of marketable securitie...
Operating lease liabilities
Amortization of premiums and acc...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
Net loss
-88,409
-82,958
Depreciation expense
5,129
5,214
Stock-based compensation expense
4,219
2,777
Amortization of premiums and accretion of discounts on marketable securities
389
827
Amortization of operating lease right-of-use assets
71
101
Prepaid expenses and other current assets
-1,519
4,377
Other assets
-17
-2,700
Accounts payable
497
5,324
Accrued expenses and other current liabilities
10,142
-15,065
Operating lease liabilities
-2,612
-2,488
Other liabilities
5,000
-
Net cash used in operating activities
-64,958
-89,801
Purchase of property and equipment
251
262
Purchase of marketable securities
79,820
306,955
Proceeds from maturities of marketable securities
126,500
104,000
Net cash used in investing activities
46,429
-203,217
Proceeds from issuance of common stock under stock plans
25
277
Proceeds from initial public offering, net of issuance costs
0
349,031
Net cash provided by financing activities
25
349,308
Net increase in cash, cash equivalents and restricted cash
-18,504
56,290
Cash, cash equivalents and restricted cash at beginning of period
169,362
113,072
Cash, cash equivalents and restricted cash at end of period
150,858
-
Cash and cash equivalents
142,613
-
Restricted cash
8,245
-
Cash, cash equivalents and restricted cash at end of period
150,858
169,362
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of marketable...
$126,500K
Proceeds from issuance of
common stock under...
$25K
Net cash used in
investing activities
$46,429K
Net cash provided by
financing activities
$25K
Canceled cashflow
$80,071K
Net increase in
cash, cash...
-$18,504K
Canceled cashflow
$46,454K
Accrued expenses and
other current...
$10,142K
Depreciation expense
$5,129K
Other liabilities
$5,000K
Stock-based compensation
expense
$4,219K
Prepaid expenses and
other current assets
-$1,519K
Accounts payable
$497K
Other assets
-$17K
Purchase of marketable
securities
$79,820K
Purchase of property and
equipment
$251K
Net cash used in
operating activities
-$64,958K
Canceled cashflow
$26,523K
Net loss
-$88,409K
Operating lease
liabilities
-$2,612K
Amortization of premiums and
accretion of discounts on...
$389K
Amortization of operating
lease right-of-use...
$71K
Buy us a coffee